Islande < Israël < Italie

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]

Ident.	Authors (with country if any)	Title
000065 (2020)	Gali Epstein Shochet [Israël] ; Elizabetha Brook [Israël] ; Becky Bardenstein-Wald [Israël] ; David Shitrit [Israël]	TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.
000122 (2020)	Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]	Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000490 (2019)	Elinoar Hoffman [Israël] ; Michal A. Rahat [Israël] ; Joy Feld [Israël] ; Muna Elias [Israël] ; Itzhak Rosner [Israël] ; Lisa Kaly [Israël] ; Idit Lavie [Israël] ; Tal Gazitt [Israël] ; Devy Zisman [Israël]	Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis.
000493 (2019)	Itay Lotan [Israël] ; Robert W. Charlson [États-Unis] ; Lana Zhovtis Ryerson [États-Unis] ; Michael Levy [États-Unis] ; Ilya Kister [États-Unis]	Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders.
000568 (2019)	Uri Arad [Israël] ; Ori Elkayam [Israël]	Association of Serum Tocilizumab Trough Concentrations with Clinical Disease Activity Index Scores in Adult Patients with Rheumatoid Arthritis.
000619 (2018)	Hasini Jayatilaka [États-Unis] ; Fatima G. Umanzor [États-Unis] ; Vishwesh Shah [États-Unis] ; Tomer Meirson [Israël] ; Gabriella Russo [États-Unis] ; Bartholomew Starich [États-Unis] ; Pranay Tyle [États-Unis] ; Jerry S H. Lee [États-Unis] ; Shyam Khatau [États-Unis] ; Hava Gil-Henn [Israël] ; Denis Wirtz [États-Unis]	Tumor cell density regulates matrix metalloproteinases for enhanced migration.
000749 (2018)	Galia Zacay [Israël] ; Yair Levy [Israël]	Outcomes of patients with systemic sclerosis treated with tocilizumab: Case series and review of the literature.
000855 (2018)	Mahmoud Abu-Shakra [Israël] ; Devy Zisman [Israël] ; Alexandra Balbir-Gurman [Israël] ; Howard Amital [Israël] ; Yair Levy [Israël] ; Pnina Langevitz [Israël] ; Moshe Tishler [Israël] ; Yair Molad [Israël] ; Suhail Aamar [Israël] ; Itzhak Roser [Israël] ; Nina Avshovich [Israël] ; Daphna Paran [Israël] ; Tatiana Reitblat [Israël] ; Reuven Mader ; Hillel Savin [Israël] ; Joshua Friedman [Israël] ; Nicky Lieberman [Israël] ; Sharon Ehrlich [Israël]	Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis.
000978 (2017)	Mitsuhiro Akiyama [Israël]	Trial of Tocilizumab in Giant-Cell Arteritis.
000A12 (2017)	Tawfik Khoury [Israël] ; Vered Molho-Pessach [Israël] ; Yuval Ramot [Israël] ; Abu Rmeileh Ayman [Israël] ; Orly Elpeleg [Israël] ; Neville Berkman [Israël] ; Abraham Zlotogorski [Israël] ; Yaron Ilan [Israël]	Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome.
000A59 (2017)	Jeffrey R. Curtis [États-Unis] ; Lang Chen [États-Unis] ; Phillip Higginbotham [États-Unis] ; W Benjamin Nowell [États-Unis] ; Ronit Gal-Levy [Israël] ; James Willig [États-Unis] ; Monika Safford [États-Unis] ; Joseph Coe [États-Unis] ; Kaitlin O'Hara [États-Unis] ; Roee Sa'Adon [Israël]	Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising.
000D16 (2016)	Julianna Hirsch [Israël] ; Itzhak Rosner [Israël] ; Doron Rimar [Israël] ; Lisa Kaly [Israël] ; Michael Rozenbaum [Israël] ; Nina Boulman [Israël] ; Gleb Slobodin [Israël]	Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis.
000E64 (2016)	Simon Tarp [Danemark] ; Gil Amarilyo [Israël] ; Ivan Foeldvari ; Robin Christensen [Danemark] ; Jennifer M P. Woo [États-Unis] ; Neta Cohen [Israël] ; Tracy D. Pope [États-Unis] ; Daniel E. Furst [États-Unis]	Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials.
000F19 (2016)	Gil Amarilyo [Israël] ; Simon Tarp [Danemark] ; Ivan Foeldvari [Allemagne] ; Neta Cohen [Israël] ; Tracy D. Pope [États-Unis] ; Jennifer M P. Woo [États-Unis] ; Robin Christensen [Danemark] ; Daniel E. Furst [États-Unis]	Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials.
000F76 (2015)	O. Shovman [Israël] ; Y. Shoenfeld ; P. Langevitz	Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.
001171 (2015)	T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi [Suisse] ; Corrado Bernasconi [Suisse] ; Maxime Dougados [France]	Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study.
001253 (2014)	Ori Elkayam [Israël] ; Nizar Jiries ; Zvi Dranitzki ; Shay Kivity ; Merav Lidar ; Ofer Levy ; Jacob Ablin ; Mahmoud Abu-Shakra ; Hagit Savargyl-Maman ; Hagit Padova ; Dan Caspi ; Itzhak Rosner	Tocilizumab in adult-onset Still's disease: the Israeli experience.
001452 (2013)	Said Younis [Israël] ; Itzhak Rosner ; Doron Rimar ; Nina Boulman ; Michael Rozenbaum ; Majed Odeh ; Gleb Slobodin	Weight change during pharmacological blockade of interleukin-6 or tumor necrosis factor-α in patients with inflammatory rheumatic disorders: a 16-week comparative study.
001567 (2013)	Said Younis [Israël] ; Itzhak Rosner ; Doron Rimar ; Nina Boulman ; Michael Rozenbaum ; Majed Odeh ; Gleb Slobodin	Interleukin 6 blockade-associated weight gain with abdominal enlargement in a patient with rheumatoid arthritis.
001621 (2013)	Ziv Rosman [Israël] ; Yehuda Shoenfeld ; Gisele Zandman-Goddard	Biologic therapy for autoimmune diseases: an update.
001679 (2012)	Lisa Kaly [Israël] ; Itzhak Rosner	Tocilizumab - a novel therapy for non-organ-specific autoimmune diseases.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffPays.i -k "Israël" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffPays.i  \
                -Sk "Israël" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Israël
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021